MBX
#1716
MBX Biosciences, Inc. - Common Stock
63.0 0 USD
-0.05%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-5.11%
Variación mensual
-4.53%
Variación en los últimos 6 meses
+102.18%
Cambio anual
+321.69%
Cierres anteriores
66.3 9
Open
63.0 0
Mínimo
63.0 0
Máximo
63.0 0
Volumen
79
Financials
- Market Capitalization 3.03 B
- Employee 63
- Founded 2018
- CEO N/A
- Website www.mbxbio.com
- Headquarter Delaware, United States
- FIGI BBG00W7W53M5
- Industry Fabricantes de medicamentos — general
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1497 |  MANE Veradermics, Incorporated Common Stock | 97.84 USD | -3.69% | -4.65% | -4.22% | +196.48% | 4.09 B USD | ||
| 1579 |  OGN Organon & Co. Common Stock | 13.77 USD | +0.07% | +0.36% | +1.55% | +89.67% | 3.62 B USD | ||
| 1896 |  RAPP Rapport Therapeutics, Inc. - Common Stock | 47.73 USD | -2.13% | -3.01% | +16.90% | +82.25% | 2.29 B USD | ||
| 1954 |  PVLA Palvella Therapeutics, Inc. - Common Stock | 149.97 USD | -0.24% | +7.11% | +8.63% | +103.07% | 2.16 B USD |